Remove 2025 Remove Spine Remove Treatment
article thumbnail

Email marketing is not dead

Chiropractic Economics

billion in 2025. These emails can also include helpful tips to prepare for their visit, links to online forms or special offers for follow-up treatments, creating a seamless experience for your patients. For example, 5 Simple Ways to Keep Your Spine Healthy or “Miss Your Spine Feeling Fine? Its Time for a Tune-Up!”

article thumbnail

Los Angeles Neurosurgeon, Dr. Albert Wong, Joins Elite Surgeons at Arthrex to Advance Endoscopic Minimally Invasive Spine Surgery

OrthoSpineNews

Dr.Albert Wongwill join an elite group of surgeons at Arthrex inFort Myers, Florida, onJanuary 24-25, 2025, to advance and teach cutting-edge techniques in endoscopic minimally invasive spine surgery, focusing on tissue-sparing approaches that enhance patient outcomes with faster recovery times and reduced surgical pain.

Spine 59
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Congress reintroduces Chiropractic Medicare Coverage Modernization Act

Chiropractic Economics

For the past 50 years, citing no scientific or policy basis, Medicare has limited beneficiaries to coverage of one chiropractic service, manual manipulation of the spine. Tammy Baldwin (D-Wis.), Chris Coons (D-Del.), Steve Daines (R-Mont.), Martin Heinrich (D-N.M.), John Hoeven (R-N.D.), Amy Klobuchar (D-Minn.), Jerry Moran (R-Kan.),

article thumbnail

Your First Visit to the Chiropractor

Healthy Life Chiropractic

Are you looking to get 2025 off to a healthy start? This hands-on evaluation is crucial for tailoring treatment just for you. In some cases, additional tests like X-rays may be recommended to gain deeper insights into your spine's condition and ensure the safety of treatment. Start by giving yourself time to relax.

article thumbnail

Mainstay Medical Announces Positive Results from the Landmark ReActiv8® RESTORE Clinical Trial

OrthoSpineNews

DUBLIN, January 15, 2025–( BUSINESS WIRE )–Mainstay Medical Holdings plc today announced the publication of positive one-year primary assessment results of the RESTORE randomized clinical trial of ReActiv8 for the treatment of intractable chronic low back pain. for the ReActiv8 group vs. -2.9 for the control group.

Clinic 52
article thumbnail

A breakthrough in noninvasive low back pain treatment

Chiropractic Economics

1 Associated to LBP, lumbar spine osteoarthritis (OA) is particularly common, with prevalence estimates ranging from 40% to 85%. 3,4 However, recent advancements in regenerative medicine present a promising alternative: noninvasive topical treatments derived from stem cells. p < 0.0001, baseline versus post-treatment.

Treatment 264
article thumbnail

Spine BioPharma, Inc. to Present at Biotech Showcase 2025

OrthoSpineNews

January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc., January 7, 2025, NEW YORK–( BUSINESS WIRE )–Spine BioPharma, Inc., SB-01 modulates TGF-Beta concentration, without eliminating it, mitigating the negative downstream effects.